在严重的ARDS中,社会经济地位和ECMO结果
Diane Naouri1, Matthieu Jamme1,2, Alain Combes3
1Direction de la recherche, des études, de l'évaluation et des statistiques (DREES), Ministère du Travail, de la Santé, des Solidarités et de la Famille, Paris, France.
Annals of intensive care
|March 6, 2026
概括
需要体外膜氧化 (ECMO) 的严重急性呼吸困扰综合征 (ARDS) 患者更有可能来自社会经济贫困地区. 然而,社会经济地位并没有影响这种重症监护环境中的患者结果.
科学领域:
- 关键护理医学 关键护理医学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 社会经济地位与重症COVID-19患者的不良结果有关.
- 不确定性存在于严重急性呼吸困扰综合征 (ARDS) 患者的差异,患者接受体外膜氧化 (ECMO) 治疗,无论原因如何.
- 这项研究调查了ECMO的ARDS患者的社会经济概况,管理和结果,将COVID-19病例与其他病因进行比较.
研究的目的:
- 根据COVID-19状态,在ECMO上比较ARDS患者的社会经济概况.
- 分析不同病因的ECMOARDS患者的管理和结果.
- 确定社会经济贫困是否影响严重ARDS患者需要ECMO的结果.
主要方法:
- 利用法国全国范围的医疗保健数据库.
- 包括从2015年3月至2021年12月接受ECMO治疗急性呼吸衰竭的1722名成年患者.
- 根据病因分类的患者:COVID-19,流感和其他原因.
主要成果:
- 27%的ECMO患者居住在贫困社区,在COVID-19,流感和其他ARDS病因方面也有类似的过度代表性 (p=0.039).
- 住院死亡率为COVID-19的56%,流感的48%,其他原因的60% (p=0.080).
- 社会经济贫困与住院死亡没有独立相关;在ECMO启动时,年龄较大和脏替代疗法是死亡率的预测因素.
结论:
- 严重的ARDS需要ECMO不成比例地影响来自社会经济贫困地区的个人,无论其根本原因是什么.
- 尽管患病率较高,但社会经济贫困与ECMO治疗的ARDS患者的更差结果无关.
- 在调整后,非COVID-19,非流感ARDS患者的死亡率高于流感患者.
相关概念视频
Acute Respiratory Failure-II
1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Respiratory Failure-V
564
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
564
Acute Respiratory Failure-III
1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Acute Respiratory Failure-I
1.3K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
Acute Respiratory Failure-IV
638
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
638
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
576
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
576

